VVTMF (VVT Med) ROCE %: 0.00% (As of Sep. 2025)


VVTMF VVT Med Inc VVTMF
6 GF Score
Price $0.02
! 4 Warning Signs
View Full Analysis

What is VVT Med ROCE %?

VVT Med VVTMF 6 ROCE % is 0.00% as of Sep. 2025. GuruFocus rates VVTMF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. VVT Med's annualized ROCE % for the quarter that ended in Sep. 2025 was 0.00%.

VVT Med  (OTCPK:VVTMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

VVT Med ROCE % Related Terms

VVT Med ROCE % Historical Data

* Premium members only.

The historical data trend for VVT Med's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med ROCE % Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24
ROCE %
0.00 0.00 0.00

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
VVTMF
6GF Score
VVT Med Inc VVTMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VVT Med ROCE % Calculation

VVT Med's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-0.639/( ( (0.889 - 4.546) + (0.985 - 6.709) )/ 2 )
=-0.639/( (-3.657+-5.724)/ 2 )
=-0.639/-4.6905
=13.62 %

VVT Med's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=-8.844/( ( (1.317 - 5.059) + (1.931 - 1.917) )/ 2 )
=-8.844/( ( -3.742 + 0.014 )/ 2 )
=-8.844/-1.864
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
VVT Med (VVTMF) has a ROCE % of 0.00% as of Sep. 2025.
Is VVT Med's ROCE % too high?
VVT Med's current ROCE % is 0.00%. Overall, VVT Med has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's ROCE % compare to ABT and SYK?
VVT Med's ROCE % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. VVT Med's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For VVT Med (VVTMF), the current ROCE % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
6GF Score

Get the complete analysis for VVTMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price